Emany Sravan Kumar, CFO of Beam Therapeutics Inc. ($BEAM), sold $170,567 worth of shares on the open market once in the last 365 days, with the most recent sale on December 31, 2025. This ranks 8,756th among 11,678 insiders in our database, well below the average sale of $8.6 million over 6.37 transactions. No open market purchases recorded.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Beam Therapeutics Inc. | $BEAM | Emany Sravan Kumar | Chief Financial Officer | A | Common Stock | 31750 | $0.00 | 105,456.0000 | 102,570,801 | 43.08% | 0.03% |
| Feb. 24, 2026 | Kyverna Therapeutics, Inc. | $KYTX | Emany Sravan Kumar | Not found | A | Stock Option (right to buy) | 42945 | $0.00 | 42,945.0000 | 43,796,170 | 9999.99% | 0.10% |
| Feb. 24, 2026 | Kyverna Therapeutics, Inc. | $KYTX | Emany Sravan Kumar | Not found | A | Common Stock | 11006 | $0.00 | 11,006.0000 | 43,796,170 | 9999.99% | 0.03% |
| Jan. 31, 2026 | Beam Therapeutics Inc. | $BEAM | Emany Sravan Kumar | Chief Financial Officer | A | Stock Option (Right to Buy) | 63500 | $0.00 | 63,500.0000 | 102,570,801 | 9999.99% | 0.06% |
| Dec. 31, 2025 | Beam Therapeutics Inc. | $BEAM | Emany Sravan Kumar | Chief Financial Officer | S | Common Stock | 6294 | $27.10 | 73,706.0000 | 102,570,801 | 7.87% | 0.01% |
| May 7, 2025 | Assertio Holdings, Inc. | $ASRT | Emany Sravan Kumar | Director | A | Common Stock | 53750 | $0.00 | 285,070.0000 | 95,271,000 | 23.24% | 0.06% |
| May 7, 2025 | Assertio Holdings, Inc. | $ASRT | Emany Sravan Kumar | Director | A | Stock Option (right to buy) | 81225 | $0.00 | 81,225.0000 | 95,271,000 | 9999.99% | 0.09% |
| Dec. 31, 2024 | Beam Therapeutics Inc. | $BEAM | Emany Sravan Kumar | Chief Financial Officer | A | Common Stock | 80000 | $0.00 | 80,000.0000 | 82,410,095 | 9999.99% | 0.10% |
| Dec. 31, 2024 | Beam Therapeutics Inc. | $BEAM | Emany Sravan Kumar | Chief Financial Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 82,410,095 | 9999.99% | 0.19% |
| Nov. 18, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, COO and CFO | S | Class A Common Stock | 11001 | $4.08 | 309,572.0000 | 160,232,000 | 3.43% | 0.01% |
| May 23, 2024 | Assertio Holdings, Inc. | $ASRT | Emany Sravan Kumar | Director | A | Common Stock | 53750 | $0.00 | 231,320.0000 | 71,031,000 | 30.27% | 0.08% |
| May 23, 2024 | Assertio Holdings, Inc. | $ASRT | Emany Sravan Kumar | Director | A | Stock Option (right to buy) | 81225 | $0.00 | 81,225.0000 | 71,031,000 | 9999.99% | 0.11% |
| May 16, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | F | Class A Common Stock | 18280 | $6.64 | 320,573.0000 | 157,700,000 | 5.39% | 0.01% |
| March 8, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | M | Class A Common Stock | 37120 | $0.00 | 338,853.0000 | 155,435,000 | 12.30% | 0.02% |
| March 8, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | M | Performance-based Restricted Stock Unit | 37120 | $0.00 | 0.0000 | 155,435,000 | 100.00% | 0.02% |
| March 4, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | P | Class A Common Stock | 10684 | $9.38 | 301,733.0000 | 155,435,000 | 3.67% | 0.01% |
| Feb. 12, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Performance-based Restricted Stock Unit | 32656 | $0.00 | 32,656.0000 | 155,435,000 | 9999.99% | 0.02% |
| Feb. 12, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Class A Common Stock | 65312 | $0.00 | 291,049.0000 | 155,435,000 | 28.93% | 0.04% |
| Feb. 8, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | F | Class A Common Stock | 41332 | $14.90 | 225,737.0000 | 155,435,000 | 15.48% | 0.03% |
| Jan. 17, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Class A Common Stock | 85000 | $0.00 | 267,069.0000 | 155,435,000 | 46.69% | 0.05% |
| Nov. 16, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | F | Class A Common Stock | 6661 | $9.44 | 182,069.0000 | 186,891,000 | 3.53% | 0.00% |
| Nov. 14, 2023 | Assertio Holdings, Inc. | $ASRT | Emany Sravan Kumar | Director | A | Stock Option (right to buy) | 26308 | $0.00 | 26,308.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2023 | Assertio Holdings, Inc. | $ASRT | Emany Sravan Kumar | Director | A | Common Stock | 177570 | $0.00 | 177,570.0000 | 0 | 9999.99% | 0.00% |
| Sept. 15, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | P | Class A Common Stock | 36072 | $8.32 | 188,730.0000 | 155,367,000 | 23.63% | 0.02% |
| March 8, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Performance-based Restricted Stock Units | 37118 | $0.00 | 37,118.0000 | 186,312,000 | 9999.99% | 0.02% |
| March 8, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Class A Common Stock | 74236 | $0.00 | 152,658.0000 | 186,312,000 | 94.66% | 0.04% |